ATE294177T1 - Pyridazino-quinolin derivat und verfahren zur behandlung von schmerz - Google Patents

Pyridazino-quinolin derivat und verfahren zur behandlung von schmerz

Info

Publication number: ATE294177T1
Authority: AT; Austria
Prior art keywords: pyridazino; treating pain; quinoline derivative; quinoline; derivative
Prior art date: 1999-12-23

Application number

AT00987935T

Other languages

English (en)

Inventor

Thomas Michael Bare

Dean Gordon Brown

Megan Murphy

Rebecca Ann Urbanek

Wenhua Xiao

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-23

Filing date

2000-12-19

Publication date

2005-05-15

2000-12-19 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2005-05-15 Application granted granted Critical

2005-05-15 Publication of ATE294177T1 publication Critical patent/ATE294177T1/de

Links

BOYBQQBDCOIBIR-UHFFFAOYSA-N pyrido[2,3-f]cinnoline Chemical class N1=CC=C2C3=NC=CC=C3C=CC2=N1 BOYBQQBDCOIBIR-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/503—Pyridazines; Hydrogenated pyridazines spiro-condensed
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT00987935T 1999-12-23 2000-12-19 Pyridazino-quinolin derivat und verfahren zur behandlung von schmerz ATE294177T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US17190699P	1999-12-23	1999-12-23
US23678300P	2000-09-29	2000-09-29
PCT/SE2000/002611 WO2001047927A1 (en)	1999-12-23	2000-12-19	Compound and method for the treatment of pain

Publications (1)

Publication Number	Publication Date
ATE294177T1 true ATE294177T1 (de)	2005-05-15

Family

ID=26867555

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00987935T ATE294177T1 (de)	1999-12-23	2000-12-19	Pyridazino-quinolin derivat und verfahren zur behandlung von schmerz

Country Status (29)

Country	Link
EP (1)	EP1244662B1 (de)
JP (1)	JP2003519149A (de)
KR (1)	KR20020062369A (de)
CN (1)	CN1188413C (de)
AR (1)	AR027037A1 (de)
AT (1)	ATE294177T1 (de)
AU (1)	AU779703B2 (de)
BG (1)	BG106831A (de)
BR (1)	BR0016654A (de)
CA (1)	CA2394888A1 (de)
CO (1)	CO5271689A1 (de)
CZ (1)	CZ296877B6 (de)
DE (1)	DE60019807T2 (de)
DK (1)	DK1244662T3 (de)
EE (1)	EE200200350A (de)
ES (1)	ES2239632T3 (de)
HK (1)	HK1048811B (de)
HU (1)	HUP0300313A3 (de)
IL (1)	IL150208A0 (de)
IS (1)	IS6427A (de)
MX (1)	MXPA02006155A (de)
MY (1)	MY133596A (de)
NO (1)	NO20022984L (de)
NZ (1)	NZ519390A (de)
PL (1)	PL356664A1 (de)
PT (1)	PT1244662E (de)
RU (1)	RU2234507C2 (de)
SK (1)	SK8792002A3 (de)
WO (1)	WO2001047927A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0403172D0 (sv) *	2004-12-23	2004-12-23	Astrazeneca Ab	Manufacturing process
EP2074992B1 (de) *	2005-04-08	2015-05-20	Abbott Laboratories	Orale Pharmazeutische Formulierungen enthaltend Salze von Fenofibrinsäure
JP5790533B2 (ja) *	2012-02-14	2015-10-07	住友化学株式会社	フェニルヒドラジン−β−カルボキシレート化合物の精製方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9420590D0 (en) *	1993-10-22	1994-11-30	Zeneca Ltd	Pyridazino quinoline compounds

2000
- 2000-12-19 SK SK879-2002A patent/SK8792002A3/sk unknown
- 2000-12-19 HK HK03100925.7A patent/HK1048811B/en not_active IP Right Cessation
- 2000-12-19 PT PT00987935T patent/PT1244662E/pt unknown
- 2000-12-19 EP EP00987935A patent/EP1244662B1/de not_active Expired - Lifetime
- 2000-12-19 JP JP2001549397A patent/JP2003519149A/ja active Pending
- 2000-12-19 CZ CZ20022177A patent/CZ296877B6/cs not_active IP Right Cessation
- 2000-12-19 HU HU0300313A patent/HUP0300313A3/hu unknown
- 2000-12-19 CN CNB008174318A patent/CN1188413C/zh not_active Expired - Fee Related
- 2000-12-19 DE DE60019807T patent/DE60019807T2/de not_active Expired - Fee Related
- 2000-12-19 MX MXPA02006155A patent/MXPA02006155A/es active IP Right Grant
- 2000-12-19 EE EEP200200350A patent/EE200200350A/xx unknown
- 2000-12-19 RU RU2002115270/04A patent/RU2234507C2/ru not_active IP Right Cessation
- 2000-12-19 PL PL00356664A patent/PL356664A1/xx not_active Application Discontinuation
- 2000-12-19 NZ NZ519390A patent/NZ519390A/en unknown
- 2000-12-19 CA CA002394888A patent/CA2394888A1/en not_active Abandoned
- 2000-12-19 IL IL15020800A patent/IL150208A0/xx unknown
- 2000-12-19 DK DK00987935T patent/DK1244662T3/da active
- 2000-12-19 KR KR1020027008043A patent/KR20020062369A/ko not_active Ceased
- 2000-12-19 ES ES00987935T patent/ES2239632T3/es not_active Expired - Lifetime
- 2000-12-19 BR BR0016654-5A patent/BR0016654A/pt not_active IP Right Cessation
- 2000-12-19 AU AU24203/01A patent/AU779703B2/en not_active Ceased
- 2000-12-19 AT AT00987935T patent/ATE294177T1/de not_active IP Right Cessation
- 2000-12-19 WO PCT/SE2000/002611 patent/WO2001047927A1/en not_active Ceased
- 2000-12-20 AR ARP000106797A patent/AR027037A1/es not_active Application Discontinuation
- 2000-12-21 CO CO00097100A patent/CO5271689A1/es not_active Application Discontinuation
- 2000-12-21 MY MYPI20006091A patent/MY133596A/en unknown
2002
- 2002-06-18 BG BG106831A patent/BG106831A/xx unknown
- 2002-06-19 IS IS6427A patent/IS6427A/is unknown
- 2002-06-20 NO NO20022984A patent/NO20022984L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2394888A1 (en)	2001-07-05
NO20022984D0 (no)	2002-06-20
DE60019807T2 (de)	2006-01-19
HUP0300313A2 (hu)	2003-06-28
BG106831A (en)	2003-03-31
AU2420301A (en)	2001-07-09
HK1048811B (en)	2005-09-30
CZ20022177A3 (cs)	2002-11-13
CZ296877B6 (cs)	2006-07-12
WO2001047927A1 (en)	2001-07-05
BR0016654A (pt)	2002-09-03
PT1244662E (pt)	2005-07-29
RU2234507C2 (ru)	2004-08-20
CN1411459A (zh)	2003-04-16
EP1244662B1 (de)	2005-04-27
NO20022984L (no)	2002-08-20
CN1188413C (zh)	2005-02-09
AU779703B2 (en)	2005-02-10
SK8792002A3 (en)	2003-05-02
IL150208A0 (en)	2002-12-01
MXPA02006155A (es)	2002-12-05
KR20020062369A (ko)	2002-07-25
IS6427A (is)	2002-06-19
HK1048811A1 (en)	2003-04-17
ES2239632T3 (es)	2005-10-01
DK1244662T3 (da)	2005-07-11
NZ519390A (en)	2003-07-25
PL356664A1 (en)	2004-06-28
MY133596A (en)	2007-11-30
EP1244662A1 (de)	2002-10-02
DE60019807D1 (de)	2005-06-02
EE200200350A (et)	2003-10-15
JP2003519149A (ja)	2003-06-17
AR027037A1 (es)	2003-03-12
HUP0300313A3 (en)	2007-05-02
CO5271689A1 (es)	2003-04-30

Legal Events

Date

Code

Title

Description

2006-01-15

UEP

Publication of translation of european patent specification

Ref document number: 1244662

Country of ref document: EP

2007-09-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69925266D1 (de)	2005-06-16	Verfahren und gerät zur behandlung von herzarhythmie
DE69807538D1 (de)	2002-10-10	Vorrichtung und Verfahren zur Behandlung von Gewebe
DE60011918D1 (de)	2004-08-05	Vorrichtung und verfahren zur lokalen behandlung von wasser
DE60231601D1 (de)	2009-04-30	Einrichtung und verfahren zur behandlung
DE60122532D1 (de)	2006-10-05	Verfahren zur behandlung von mehreren bohrlochintervallen
ATE230617T1 (de)	2003-01-15	Verfahren und methode zur behandlung von abfällen
DE69829336D1 (de)	2005-04-21	Vorrichtung und Verfahren zur Behandlung von Körpergewebe
DE69730097D1 (de)	2004-09-09	Verfahren und Vorrichtung zur Behandlung von Wafers
ATE230606T1 (de)	2003-01-15	Verfahren zur vorbeugung und behandlung von allergien
DE69841399D1 (de)	2010-02-04	Vorrichtung und Verfahren zur Trocknungsbehandlung
DE60116447D1 (de)	2006-03-30	Verfahren und System zur Verbindungsbehandlung
DE69806970D1 (de)	2002-09-05	Verfahren zur behandlung von hartgeweben
DE69726289D1 (de)	2003-12-24	Verfahren und zusammensetzung zur behandlung von substraten bezüglich benetzbarkeit
DE69918306T2 (de)	2004-10-21	Verfahren und vorrichtung zur behandlung von arrythmien
DE60002199D1 (de)	2003-05-22	Verfahren und anordnung zur behandlung von milch
DE60023623D1 (de)	2005-12-08	Vorrichtung und Verfahren zur Behandlung leicht polymerisierbarer Komponenten
EP1635801A4 (de)	2008-01-23	Verfahren zur behandlung und prävention von herzarrhythmie
ATE224652T1 (de)	2002-10-15	Verfahren und einrichtung zur behandlung von tabak
DE60010750D1 (de)	2004-06-17	Verfahren und einrichtung zur behandlung von textilwaren
EP1200538A4 (de)	2003-04-16	Verfahren zur behandlung von petroleumsäuren
DE60036899D1 (de)	2007-12-13	Chemikalie und verfahren zur wasserbehandlung
DE50213931D1 (de)	2009-11-26	Verfahren und vorrichtung zur behandlung von fehlerverdacht
ATE307871T1 (de)	2005-11-15	Verfahren zur behandlung von gewebe
DE69935858D1 (de)	2007-05-31	Verfahren und vorrichtung zur behandlung von scheiben
DE50006527D1 (de)	2004-06-24	Verfahren und vorrichtung zum behandeln von drähten